ARCHIVES

FDA Simplifies Reporting Of Adverse Events

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

Carter Request Only $878.8 Million For NCI

January 27, 1978

Cooperative Group Trials Approved By NCI Are Listed

August 26, 2005

GAO Criticize NCI Contract Practices In Report On Cancer Control

July 25, 1980

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003